Quarterly ResultJul 29, 2026, 06:12 AM
Clarivate Q2 Net Loss $268.6M on Impairment; Reaffirms 2026 Outlook
AI Summary
Clarivate Plc reported a net loss of $268.6 million, or $(0.42) per diluted share, for Q2 2026, primarily due to a $221.7 million goodwill impairment charge. Total revenues decreased 5.5% to $587.3 million, with organic revenues down 1.5%. Despite the GAAP loss, adjusted diluted EPS increased 5.6% to $0.19. The company reaffirmed its full-year 2026 financial outlook and highlighted continued progress on its Value Creation Plan, including a previously announced divestiture of its Life Sciences & Healthcare segment and a $218 million debt reduction.
Key Highlights
- Q2 2026 net loss was $268.6 million, or $(0.42) per diluted share.
- Q2 2026 total revenues decreased 5.5% to $587.3 million.
- Q2 2026 adjusted diluted EPS increased 5.6% to $0.19.
- A $221.7 million goodwill impairment charge impacted Q2 net loss.
- Total debt was reduced by $218.4 million compared to prior year.
- Reaffirmed 2026 revenue outlook of $2.30 billion to $2.42 billion.
- Reaffirmed 2026 adjusted diluted EPS outlook of $0.70 to $0.80.
- Divestiture of Life Sciences & Healthcare segment was previously announced.
Price Impact
More from CLVT